Hinge Health, Inc.
NYSE:HNGEMedical - Healthcare Information Services
-$0.24 today
- Market cap
- $9.31B
- Beta
- 1.99
- P/E (TTM)
- -10.3
- EPS (TTM)
- -$6.49
Volume 1.23M
Average 1.34M
HNGE Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Hinge Health, Inc.NYSE: HNGE
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization declines year over year
Q2 FY2026 depreciation & amortization of $1.06M fell 21.0% year over year, behind the -13.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 9.5% from the prior quarter.
Context
- Depreciation & amortization amounted to 0.9% of revenue in FY2025, down 0.7 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether quarterly growth recovers from -21.0% toward the trailing-twelve-month pace of -13.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 5.13M USD
- Year-over-year change
- -13.7%
- 2-year CAGR
- -4.5%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.13M | -13.7% |
| FY2024 | 2024-12-31 | 5.95M | +5.7% |
| FY2023 | 2023-12-31 | 5.63M | — |
Depreciation & Amortization vs competitors
How HNGE compares with its peers on the latest reported figures
- HNGE's LTM Jun 2026 depreciation & amortization of $4.72M is the lowest of the 5 companies compared; the peer median is $159.41M.
- Its year-over-year change of -13.0% is the lowest of 5, against a peer median of +7.4%.
- Depreciation & amortization amounts to 0.7% of revenue for HNGE, versus a peer median of 5.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | $459M | +2.2% | -2.3% | 7.4% | |
| LTM Apr 2026 | $296.3M | +4.8% | +10.2% | 13.0% | |
| LTM Mar 2026 | $22.52M | +10.1% | +14.9% | 3.1% | |
| LTM Mar 2026 | $5.67M | +13.1% | +8.2% | 2.0% | |
| LTM Jun 2026 | $4.72M | -13.0% | — | 0.7% | |
| Peer median (excluding HNGE) | $159.41M | +7.4% | +9.2% | 5.3% | |
Competitors are the stored peer set for HNGE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 292.73M | 390.4M | 587.86M |
| Cost of Revenue | 98.55M | 89.81M | 118.56M |
| Gross Profit | 194.18M | 300.59M | 469.3M |
| Gross Margin | 66.3% | 77.0% | 79.8% |
| Research & Development | 110.06M | 100.84M | 368.14M |
| Selling, General & Admin | 214.64M | 227.54M | 639.41M |
| Operating Expenses | 324.69M | 332.5M | 1.02B |
| Depreciation & Amortization | 5.63M | 5.95M | 5.13M |
| EBITDA | (124.89M) | (18.48M) | (535.89M) |
| EBITDA Margin | -42.7% | -4.7% | -91.2% |
| Operating Income | (130.51M) | (31.91M) | (546.37M) |
| Operating Margin | -44.6% | -8.2% | -92.9% |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 |
| Other Income / Expenses | 21.97M | 20.65M | 19.11M |
| Income Before Tax | (108.55M) | (11.26M) | (527.26M) |
| Pre-Tax Margin | -37.1% | -2.9% | -89.7% |
| Income Tax Expense | (405K) | 677K | 998K |
| Net Income | (108.14M) | (11.93M) | (528.26M) |
| Net Margin | -36.9% | -3.1% | -89.9% |
| EPS (Basic) | (1.39) | (0.15) | (5.36) |
| EPS (Diluted) | (1.39) | (0.15) | (5.19) |
| Weighted Avg Shares | 78.02M | 78.02M | 79.19M |
| Weighted Avg Shares (Diluted) | 78.02M | 78.02M | 81.7M |
Hinge Health, Inc.
NYSE:HNGE
Intrinsic Alpha fair value
Locked
Current Price
$114.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.